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Abstract
Background: The Major Depression Inventory (MDI) is a brief self-rating scale for the assessment
of depression. It is reported to be valid because it is based on the universe of symptoms of DSM-
IV and ICD-10 depression. The aim of the current preliminary study was to assess the reliability,
validity and psychometric properties of the Greek translation of the MDI.
Methods: 30 depressed patients of mean age 23.41 (± 5.77) years, and 68 controls patients of
mean age 25.08 (± 11.42) years, entered the study. In 18 of them, the instrument was re-applied
1–2 days later and the Translation and Back Translation made. Clinical diagnosis was reached with
the use of the SCAN v.2.0 and the International Personality Disorders Examination (IPDE). The
Center for Epidemiological Studies-Depression (CES-D) and the Zung Depression Rating Scale
(ZDRS) were applied for cross-validation purposes. Statistical analysis included ANOVA, the
Spearman Product Moment Correlation Coefficient, Principal Components Analysis and the
calculation of Cronbach's α.
Results: Sensitivity and specificity were 0.86 and 0.94, respectively, at 26/27. Cronbach's α for the
total scale was equal to 0.89. The Spearman's rho between MDI and CES-D was 0.86 and between
MDI and ZDRS was 0.76. The factor analysis revealed two factors but the first accounted for 54%
of variance while the second only for 9%. The test-retest reliability was excellent (Spearman's rho
between 0.53 and 0.96 for individual items and 0.89 for total score).
Conclusion: The current study provided preliminary evidence concerning the reliability and
validity of the Greek translation of the MDI. Its properties are similar to those reported in the
international literature, but further research is necessary.
Background
The Major Depression Inventory (MDI) [1] is a brief self-
rating scale for the assessment of depression. Self-report
instruments like the Beck Depression Inventory [2] and
the Zung Depression Rating Scale (ZDRS) [3], are fre-
quently used for the measurement of depression.
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However, most of these instruments are old, and had been
developed during the pre-DSM-III era. Thus, they reflect a
rather old concept concerning what depression is and
how it should be rated. These scales are supposed to be
used as screening tools rather and not as substitutes for an
in-depth interview [4]. However, during the recent years,
several instruments developed, like the Beck Depression
Inventory-2, the Inventory to Diagnose Depression and
others, in accord with the DSM-IV criteria.
The Major Depression Inventory (MDI) is reported to be
valid [5,6] because it is based on the universe of symp-
toms of DSM-IV and ICD-10 moderate to severe depres-
sion. The MDI items are measured in frequency using the
past two weeks as the time frame. It contains, in principle,
12 items, as item 8 and item 10 each have two sub-items,
a and b. Therefore, in total, the MDI contains 12 items.
Functionally, though, the MDI has only 10 items as it is
only the highest score of either a or b that count in items
8 and 10. Each scoring of the 10 items ranges from 0 (at
no time) to 5 (all of the time). Thus, the total score range
is 0–50, and there are no sub-scores. The MDI can be
scored also in an algorithmic way. In order to diagnose
major depression, the symptoms should have been
present nearly every day during the past 2 weeks. The MDI
is based on the DSM-IV and ICD-10 definitions of depres-
sion and a score of 4 or more on an item (that is, most of
the time) qualifies for the algorithm of ICD-10 or DSM-
IV. The ICD-10 algorithms of the MDI for moderate de-
pression are a score of 4 or 5 on two of the three top items
and on at least four of the remaining items. The DSM-IV
algorithm of the MDI for major depression is a score of 4
or 5 on five of the nine items (item 4 being excluded), but
at least one of these five items must be either depressed
mood or loss of interest [7].
Both scoring systems were tested in the current study.
The aim of the current preliminary study was to assess the
reliability, validity and psychometric properties of the
Greek translation of the Major Depression Inventory
(MDI).
Methods
Materials
Thirty depressed patients (12 males and 18 females) aged
23.41 ± 5.77 years (range 18–57) suffering from Major
Depressive disorder according to DSM-IV [8] and depres-
sion according to ICD-10 criteria [9], and 68 normal con-
trols (31 males and 37 females aged 25.08 (mean) ± 11.42
(std.dev.) years (range 18–52) entered the study. In 18 of
them (8 patients and 10 controls) the instrument was re-
applied 1–2 days later.
Patients were free of any medication for at least two weeks
and were physically healthy with normal clinical and lab-
oratory findings (Electroencephalogram, blood and bio-
chemical testing, thyroid function, test for pregnancy, Â12
and folic acid B12).
Patients came from the inpatient and outpatient unit of
the 3rd Department of Psychiatry, Aristotle University of
Thessaloniki, General Hospital AHEPA, Thessaloniki,
Greece. They were consecutive cases and were chosen be-
cause they fulfilled the above criteria.
The normal controls group was composed by members of
the hospital staff, and students. A clinical interview con-
firmed that they did not suffer from any mental disorder
and their prior history was free from mental and thyroid
disorder. They were free of any medication for at least two
weeks and were physically healthy.
All patients and controls provided written informed con-
sent before participating in the study.
Method
Translation and Back Translation was made by two of
the authors; one of whom did the translation and the oth-
er who did not know the original English text, did the
back translation. The final translation was fixed by con-
sensus of all authors.
Clinical Diagnosis was reached by consensus of two ex-
aminers. The Schedules for Clinical Assessment in Neu-
ropsychiatry (SCAN) version 2.0 [10,11] and the
International Personality Disorders Examination (IPDE)
[12–15] were used. Both were applied by one of the au-
thors (KNF) who has official training in a World Health
Organization Training and Reference Center. The IPDE
did not contribute to the clinical diagnosis of depression,
but was used in the frame of a global and comprehensive
assessment of the patients. The second examiner per-
formed an unstructured interview.
The Center for Epidemiological Studies-Depression (CES-
D) [16] and the Zung Depression Rating Scale (ZDRS)
[17] was applied to the subjects for purposes of cross-val-
idation. The clinical diagnosis was used as the 'gold stand-
ard' for the validation of the MDI. The use of a semi-
structured interview strengthens this approach, which
however has certain inherent limitations.
Statistical Analysis
Analysis of Variance (ANOVA) [18], was used to search for
differences between groups. Principal Components
Analysis (without and after Varimax Normalized Rota-
tion) was performed, and factor coefficients and scores
were calculated.BMC Psychiatry 2003, 3 http://www.biomedcentral.com/1471-244X/3/2
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Item Analysis [19] was performed, and the value of Cron-
bach's α for MDI was calculated. Receiver Operator Char-
acteristic Curves (ROC curves) and histogram of
frequencies were created as well.
Reliability assessment (test-retest)
The Spearman Rank Correlation Coefficient (rho) was cal-
culated to assess the test-retest reliability. However, the
calculation of correlation coefficients is not a sufficient
method to test reliability and reproducibility of a method
and its results, because it is an index of correlation and not
an index of agreement [18,20,21]. The calculation of
means and standard deviations for each MDI item and to-
tal score during the 1st (test) and 2nd (retest) applications
may provide an impression of the stability of results over
time (table 4).
Also, the means and the standard deviations of the differ-
ences concerning each MDI item between test and retest
were calculated and the plots of the test vs. retest and dif-
ference vs. average value for each variable were created. In
fact it is not possible to use statistics to define acceptable
agreement [18]. However these plots may assist decision.
It is not possible to show all of these plots, but the respect-
ed concerning the total MDI score is shown in figures 2
and 3. This method was used in previous studies concern-
ing the validation of scientific methods [22].
Also, the module of 'Process Analysis Gage Repeatability
and Reproducibility' of the Statsoft-Statistica was used to
further investigate the repeatability of the MDI with the
use of Analysis of Variance (ANOVA) [23]. The purpose of
this analysis is to determine the proportion of measure-
ment variability that is due to;
1. the subjects being assessed,
2. the MDI items (method) used for the measurement,
3. the trials (in our case: test vs. retest).
In the ideal case, only a negligible proportion of the vari-
ability will be due to trial-to-trial repeatability.
Results
The calculation of sensitivity (Sn) and specificity (Sp) at
various cut-off levels showed that the optimum combina-
tion was 0.86 for Sensitivity and 0.94 for specificity at the
score level 26/27, with 64 controls and 26 patients cor-
rectly classified. This means that a subject with a score
equal to 26 is classified as normal while a subject with a
score equal to 27 is classified as depressed. Four controls
and 4 patients were classified into a wrong diagnostic
group (table 1).
Cronbach's α for the total scale was equal to 0.89. This is
a very high value, suggesting that the MDI scale reflects a
single structure.
The histogram of MDI scores in control subjects reveals
that they do not follow the normal distribution in this
population, but rather manifest a skewness towards lower
values (figure 1).
The MDI total score correlated highly with both the CES-
D and the ZDRS. Spearman correlation coefficient was
equal to 0,86 concerning the CES-D and 0.76 concerning
the ZDRS.
The factor analysis of cases revealed the presence of two
factors (table 2). The results before and after varimax nor-
malized rotation were pretty much the same. The first fac-
tor includes all items but No 10B, and explains 54% of
variability. The second one includes only item No 10B
(increased appetite) and explains only 9% of variability.
Thus, in essence there is a single-factor solution (table 2).
Depressed patients did not differ from controls in age. On
the contrary they differed in every MDI individual item
score and total score (p < 0.001 – table 3, see additional
file 1), except of item No 10B (increased appetite).
The test-retest reliability proved to be satisfactory. Individ-
ual items had good Spearman rank correlation coeffi-
cients with the lower value concerning item No 7
(difficulty with concentration, R = 0.53) and the higher
concerning item No 8A (restlessness, R = 0.96). The coef-
ficient for the total MDI score was very good and equal to
0.91 (table 4). The bivariate scatterplot between the test
and retest values of the total MDI score (figure 2) suggests
Figure 1
Histogram of the distribution of the total MDI scores in nor-
mal subjectsBMC Psychiatry 2003, 3 http://www.biomedcentral.com/1471-244X/3/2
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that the total MDI score is a reliable variable, since the
points of the test-retest plot are very close to the regression
line (which is a dichotomous). Also, the bivariate scatter-
plot of the differences between measurements vs. the av-
erage value of measurements concerning the total MDI
score (figure 3) suggests that the total MDI score is a reli-
able variable, since all but 2 of the points of the difference
vs. average are within the 2 standard deviation range from
the mean difference.
The comparison between the values obtained during test
vs. those obtained during retest revealed no differences
(table 4). The ANOVA results (table 5) suggest that only
0.01% of total variance is due to differences inherent to
the test-retest procedure, with an additional 2.16% attrib-
utable to the interaction of this procedure with subjects
and the test itself. However this is obviously a very low
rate.
The use of DSM-IV and ICD-10 algorithms revealed very
poor performance. Their use is not recommended for
Greek patients. Most patients (although clinically diag-
nosed) had fewer than 5 DSM criteria (24 patiens with less
than 5 vs. 6 with more than 5) and fewer than 4 ICD cri-
teria (28 patiens with less than 4 vs. 2 patients with more
than 4) registered with the use of algorithms. Two control
subjects fulfilled DSM-IV criteria and 3 controls fulfilled
ICD-10 criteria for depression according to the same
algorithms.
Discussion
The present study is a preliminary effort to obtain data
concerning the psychometric properties of the Greek
translation of the MDI. The fact that results are only pre-
liminary should be stressed out, because there is a need
for further study of the properties of the scale in larger and
more representative samples.
The use of self-report scales is frequent in psychiatric re-
search. However, it is also well known that this kind of
scales heavily depend on the co-operation and reading
ability of the patient. It is also known that their
performance is influenced by the theoretical background
of their development. On the other hand they save time
for the clinician. The MDI is a new self-rating scale for de-
pression both in community and clinical settings and lit-
erature concerning its transcultural reliability and validity
is limited. The current study reports observations on the
reliability, the validity and the psychometric properties of
the Greek translation of the MDI. The results suggest that
this translation is well suited for use in the Greek popula-
tion with high sensitivity and specificity at the cut-off level
26/27, high test-retest reliability and high internal consist-
ency. Its factor structure is similar to that reported in the
literature.
In order to diagnose major depression, the symptoms
should have been present nearly every day during the past
2 weeks. The MDI is based on the DSM-IV and ICD-10
definitions of depression (and this is its major advantage
over other older and wide-spread instruments) and a
score of 4 or more on an item (that is, most of the time)
qualifies for the algorithm of ICD-10 or DSM-IV. The ICD-
10 algorithms of the MDI for moderate depression are a
score of 4 or 5 on two of the three top items and on at least
four of the remaining items. The DSM-IV algorithm of the
Table 1: Sensitivity and Specificity of Major Depression Inventory at various cut-off levels. The optimum is at level 26/27
Score level True negative 
(tn)
False possitive 
(fp)
False negative 
(fn)
True possitive 
(tp)
Sensitivity 
(Sn)
Specificity 
(Sp)
20\21 57 11 4 26 0.86 0.83
21\22 58 10 4 26 0.86 0.85
22\23 60 8 4 26 0.86 0.88
23\24 60 8 4 26 0.86 0.88
24\25 62 6 4 26 0.86 0.91
25\26 63 5 4 26 0.86 0.92
26\27 64 4 4 26 0.86 0.94
27\28 65 3 6 24 0.80 0.95
28\29 66 2 10 20 0.66 0.97
29\30 66 2 10 20 0.66 0.97
30\31 66 2 10 20 0.66 0.97
31\32 66 2 12 18 0.60 0.97
32\33 66 2 4 16 0.80 0.97
33\34 66 2 8 12 0.60 0.97
34\35 67 1 20 10 0.33 0.98
35\36 67 1 24 6 0.20 0.98BMC Psychiatry 2003, 3 http://www.biomedcentral.com/1471-244X/3/2
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MDI for major depression is a score of 4 or 5 on five of the
nine items (item 4 being excluded), but at least one of
these five items must be either depressed mood or loss of
interest [7].
However, the use of algorithms is not supported by the re-
sults of the current study. The performance of these
algorithms was very poor. The reason for this is unknown,
but it may imply that the subjects score the MDI items in
a way closer to a 'visual analog scale' and do not really fol-
low instructions.
The reliability and validity of the MDI has been tested in
a limited number of studies and no translation of this
scale has been published. This is in contrast to the large lit-
erature concerning the ZDRS [17,24–27] or the CES-D
[16,28–32].
The use of the MDI in one large population study [33] re-
vealed a favorable profile for the scale. The comparative
study of the ZDRS and MDI in 89 patients with Parkin-
son's disease [7] suggested that the MDI is superior to the
ZDRS. That study reported only one general factor for the
MDI, that explained 58.3% of variance (54% in the cur-
rent study), and higher coefficient of homogeneity in
comparison to the ZDRS. The Cronbach's α for the total
scale was equal to 0.92.
A typical standardization study [1] reported a Cronbach's
α for the total scale equal to 0.94, which is comparable to
the 0.89 reported in the current study. In that study, the
sensitivity was equal to 0.90 and the specificity was 0.82
when the MDI algorithms were used for the DSM-IV
diagnosis (this is in sharp contrast with the results of the
current study). When the cut-off point of 26/27 was used,
then the sensitivity was equal to 1.00 (0.86 in the current
one) and the specificity to 0.82 (0.94 in the current one).
Review studies on various self-administered instruments
suggest that there is no significant difference between
them in terms of performance and overall sensitivity is
around 0.84 and specificity around 0.72 [34]. These in-
struments are of particular value in primary care settings
because it is clear that primary care providers fail to diag-
nose and treat as many as 35% to 50% of patients with de-
pressive disorders[35,36]. Depression is one of the most
common psychiatric diagnoses in primary care popula-
tions [37]; major depressive disorders can be diagnosed in
6% to 9% of such patients. Obstacles to the appropriate
recognition of depression include inadequate provider
knowledge of diagnostic criteria; competing comorbid
conditions and priorities among primary care patients;
time limitations in busy office settings; concern about the
implications of labeling; poor reimbursement mecha-
nisms; and uncertainty about the value, accuracy, and ef-
ficiency of screening mechanisms for identifying patients
with depression. Given that 50% to 60% of persons
seeking help for depression are treated exclusively in the
primary care setting, accurate detection in this setting is
important[38] and self-administered instruments may
help to ameliolate some of them.
On the other hand, it should be noted that the diagnosis
of depression is itself based on symptoms. A patient can-
Figure 2
Bivariate scatterplot between the test and retest values of 
the total MDI score. The plot suggests that the total MDI 
score is a reliable variable. The points of the test-retest plot 
are very close to the regression line (which is a 
dichotomous)
Figure 3
Bivariate scatterplot of the difference between measure-
ments vs average value of measurements concerning the 
total MDI score. The plot suggests that the total MDI score 
is a reliable variable. All but 2 of the points of the difference 
vs. average are within the 2 SD from the mean difference.BMC Psychiatry 2003, 3 http://www.biomedcentral.com/1471-244X/3/2
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Table 2: Factor loadings after Factor Analysis (before and after Varimax normalized rotation) of controls and patients data
Without rotation Varimax Normalized Rotation
Factor Factor Factor Factor
MDI item No Description of item 1 2 1 2
1 Have you felt low on spirits or sad? 0.81 -0.04 0.81 -0.07
2 Have you lost interest in your daily 
activities?
0.90 -0.01 0.90 -0.05
3 Have you felt lacking in energy and 
strength?
0.81 -0.18 0.80 -0.21
4 Have you felt less self-confident? 0.84 -0.13 0.84 -0.16
5 Have you had a bad conscience or 
feelings of guilt?
0.53 0.39 0.55 0.37
6 Have you felt that life wasn't worth 
living?
0.44 0.09 0.44 0.07
7 Have you had difficulty in concentrat-
ing, e.g. when reading the newspaper 
or watching television?
0.81 0.06 0.81 0.03
8A Have you felt very restless? 0.77 0.19 0.78 0.16
8B Have you felt subdued? 0.85 -0.08 0.84 -0.11
9 Have you had trouble sleeping at 
night?
0.76 0.04 0.76 0.01
10A Have you suffered from reduced 
appetite?
0.77 0.03 0.77 0.00
10B Have you suffered from increased 
appetite?
-0.16 0.89 -0.12 0.90
Explaned Var 6.47 1.06 6.46 1.07
Prp.Totl 5 4 %9 %5 4 %9 %
Table 4: Test-retest reliability (Spearman Rank Correlation Coefficient).
test retest
MDI item No Description of item mean sd mean sd p rho
1 Have you felt low on spir-
its or sad?
2.73 1.91 2.47 1.88 0.703 0.90
2 Have you lost interest in 
your daily activities?
2.33 1.80 1.87 1.77 0.480 0.86
3 Have you felt lacking in 
energy and strength?
2.00 1.73 1.67 1.88 0.617 0.86
4 Have you felt less self-con-
fident?
1.93 1.87 1.53 1.92 0.568 0.86
5 Have you had a bad con-
science or feelings of guilt?
0.40 0.91 0.53 0.99 0.704 0.88
6 Have you felt that life 
wasn't worth living?
0.33 0.82 0.40 0.83 0.826 0.86
7 Have you had difficulty in 
concentratin g, e.g. when 
reading the newspaper or 
watching television?
1.20 1.37 1.33 1.54 0.804 0.53
8A Have you felt very 
restless?
1.87 1.81 1.87 1.81 >0.9 0.96
8B Have you felt subdued? 1.60 1.76 1.53 1.88 >0.9 0.84
9 Have you had trouble 
sleeping at night?
1.13 1.60 1.20 1.66 >0.9 0.85
10A Have you suffered from 
reduced appetite?
1.40 1.88 1.73 1.87 0.630 0.86
10B Have you suffered from 
increased appetite?
1.00 1.41 0.87 1.13 0.777 0.81
MDI total score 17.93 13.82 17.00 15.42 0.863 0.91BMC Psychiatry 2003, 3 http://www.biomedcentral.com/1471-244X/3/2
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not truly be asymptomatic and have major depressive dis-
order. Thus, these screening questionnaires are actually
being evaluated for their ability to detect unrecognized,
rather than strictly asymptomatic, depressive symptoms
and disease. They are also useful for the assessment of se-
verity but not for the diagnosis per se.
It should be also stressed that the current study offers only
preliminary data. The study sample is small; retest data are
available for only 18 subjects and the factor analysis in-
cluded both patients and controls. The complete valida-
tion demands the application of the scale in larger
samples and more sophisticated methodology, including
the use of borderline severity samples.
Conclusion
The Greek translation of the MDI scale is both reliable and
valid and is suitable for clinical and research use with sat-
isfactory properties. Its properties are similar to those re-
ported in the international literature. However one
should always have in mind the limitations inherent in
the use of self-report scales.
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